LEXX LEXARIA BIOSCIENCE CORP US FDA Inspections 8-K Filing 2024 - FDA Approval for Clinical Trial Lexaria Bioscience Corp. received FDA approval to proceed with its phase 1b hypertension clinical trial HYPER-H23-1 for DehydraTECH-CBD.Get access to all SEC 8-K filings of the LEXARIA BIOSCIENCE CORP